Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma

Post-transplant maintenance therapy with brentuximab vedotin offers greater benefit to lymphoma patients in deeper remission before transplant.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.